UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 272

Sortiert nach

Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors

Current oncology (Toronto), 2014-12, Vol.21 (6), p.329-336

2014

Volltextzugriff (PDF)

Nod2 influences microbial resilience and susceptibility to colitis following antibiotic exposure

Mucosal immunology, 2019-05, Vol.12 (3), p.720-732

2019

Volltextzugriff (PDF)

Higher Adalimumab Drug Levels are Associated with Mucosal Healing in Patients with Crohn’s Disease

Journal of Crohn's and colitis, 2016-05, Vol.10 (5), p.510-515

2016

Volltextzugriff (PDF)

Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2012-02, Vol.35 (3), p.342-349

2012

Volltextzugriff (PDF)

A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis

Nature communications, 2016-08, Vol.7 (1), p.12342-12342, Article 12342

2016

Volltextzugriff (PDF)

Increased epithelial uptake of protein antigens in the ileum of Crohn’s disease mediated by tumour necrosis factor α

Gut, 2004-12, Vol.53 (12), p.1817-1824

2004

Volltextzugriff (PDF)

Large-scale association analyses identify host factors influencing human gut microbiome composition

Nature genetics, 2021-02, Vol.53 (2), p.156-165

2021

Volltextzugriff (PDF)

Increased Intestinal Permeability Is Associated With Later Development of Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2020-12, Vol.159 (6), p.2092-2100.e5

2020

Volltextzugriff (PDF)

Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2022-11, Vol.163 (5), p.1364-1376.e10

2022

Volltextzugriff (PDF)

Cytotoxic activity of Vβ8+ T cells in Crohn's disease: the role of bacterial superantigens

Clinical and experimental immunology, 2008-06, Vol.99 (3), p.398-403

2008

Volltextzugriff (PDF)

Defining the roles of perforin, Fas/FasL, and tumour necrosis factor α in T cell induced mucosal damage in the mouse intestine

Gut, 2002-08, Vol.51 (2), p.155-163

2002

Volltextzugriff (PDF)

Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation

Gastroenterology (New York, N.Y. 1943), 2022-09, Vol.163 (3), p.685-698

2022

Volltextzugriff (PDF)

A28 A SERUM REDOX STATUS-RELATED INDICATOR IS ASSOCIATED WITH THE RISK OF ONSET OF CROHN'S DISEASE

Journal of the Canadian Association of Gastroenterology, 2024-02, Vol.7 (Supplement_1), p.15-15

2024

Volltextzugriff (PDF)

A194 EARLY LIFE WESTERN-TYPE DIET ACCELERATES THE ONSET OF MURINE IL-10 KO COLITIS

Journal of the Canadian Association of Gastroenterology, 2024-02, Vol.7 (Supplement_1), p.152-153

2024

Volltextzugriff (PDF)

Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2023-04, Vol.164 (4), p.619-629

2023

Volltextzugriff (PDF)

Detection of Species-Specific Helicobacter Ribosomal DNA in Intestinal Biopsy Samples from a Population-Based Cohort of Patients with Ulcerative Colitis

Journal of Clinical Microbiology, 2004-02, Vol.42 (2), p.660-664

2004

Volltextzugriff (PDF)

P468 Relevance of anti-drug antibodies in context of supra-therapeutic anti-TNF concentrations

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i940-i941

2024

Volltextzugriff (PDF)

Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—Prediction and Prevention of Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2021-09, Vol.15 (9), p.1443-1454

2021

Volltextzugriff (PDF)

T-cell–induced mucosal damage in the intestine

Current opinion in gastroenterology, 2004-11, Vol.20 (6), p.581-586

2004

Volltextzugriff (PDF)

A39 HEALTHY FIRST-DEGREE RELATIVES FROM MULTIPLEX FAMILIES VERSUS SIMPLEX HARBOR A HIGHER RISK OF DEVELOPING CROHN'S DISEASE AND ARE ASSOCIATED WITH SUBCLINICAL INFLAMMATION AND ALTERED MICROBIOME COMPOSITION

Journal of the Canadian Association of Gastroenterology, 2023-03, Vol.6 (Suppl 1), p.21-22

2023

Volltextzugriff (PDF)

A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease

Gastroenterology (New York, N.Y. 1943), 1997-04, Vol.112 (4), p.1069-1077

1997

Volltextzugriff (PDF)

A103 COMBINATORIAL EFFECT OF EARLY LIFE ANTIBIOTIC EXPOSURE AND HIGH-FAT DIET ON COLITIS SUSCEPTIBILITY

Journal of the Canadian Association of Gastroenterology, 2019-03, Vol.2 (Supplement_2), p.205-206

2019

Volltextzugriff (PDF)

P244 The first step to IBD prevention exploring rate of pre-clinical inflammation in subset of asymptomatic subjects at risk of IBD: screening stage of the PIONIR trial

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i592-i593

2024

Volltextzugriff (PDF)

A261 INVESTIGATING THE RELATIONSHIP BETWEEN AIR POLLUTION AND BIOMARKERS OF CROHN’S DISEASE IN CANADA

Journal of the Canadian Association of Gastroenterology, 2024-02, Vol.7 (Supplement_1), p.210-210

2024

Volltextzugriff (PDF)

A196 CSF2 AUTOANTIBODIES AS A SEROLOGICAL MARKER FOR CROHN'S DISEASE

Journal of the Canadian Association of Gastroenterology, 2024-02, Vol.7 (Supplement_1), p.154-155

2024

Volltextzugriff (PDF)

1 – 25 von 272

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(244)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(147)
Life Sciences & Biomedicine
(89)
Humans
(62)
Technology
(53)
Physical Sciences
(52)
Physics
(51)
Physics, Applied
(46)
Female
(40)
Computer Science
(39)
Computer Science, Information Systems
(38)
Engineering
(38)
Engineering, Electrical & Electronic
(38)
Animals
(37)
Biological And Medical Sciences
(37)
Male
(37)
Gastroenterology & Hepatology
(32)
Mice
(31)
Medical Sciences
(28)
Adult
(23)
Immunology
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors

Nod2 influences microbial resilience and susceptibility to colitis following antibiotic exposure

Higher Adalimumab Drug Levels are Associated with Mucosal Healing in Patients with Crohn’s Disease

Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease

A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis

Increased epithelial uptake of protein antigens in the ileum of Crohn’s disease mediated by tumour necrosis factor α

Large-scale association analyses identify host factors influencing human gut microbiome composition

Increased Intestinal Permeability Is Associated With Later Development of Crohn’s Disease

Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease

Cytotoxic activity of Vβ8+ T cells in Crohn's disease: the role of bacterial superantigens

Defining the roles of perforin, Fas/FasL, and tumour necrosis factor α in T cell induced mucosal damage in the mouse intestine

Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation

A28 A SERUM REDOX STATUS-RELATED INDICATOR IS ASSOCIATED WITH THE RISK OF ONSET OF CROHN'S DISEASE

A194 EARLY LIFE WESTERN-TYPE DIET ACCELERATES THE ONSET OF MURINE IL-10 KO COLITIS

Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis

Detection of Species-Specific Helicobacter Ribosomal DNA in Intestinal Biopsy Samples from a Population-Based Cohort of Patients with Ulcerative Colitis

P468 Relevance of anti-drug antibodies in context of supra-therapeutic anti-TNF concentrations

Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—Prediction and Prevention of Inflammatory Bowel Disease

T-cell–induced mucosal damage in the intestine

A39 HEALTHY FIRST-DEGREE RELATIVES FROM MULTIPLEX FAMILIES VERSUS SIMPLEX HARBOR A HIGHER RISK OF DEVELOPING CROHN'S DISEASE AND ARE ASSOCIATED WITH SUBCLINICAL INFLAMMATION AND ALTERED MICROBIOME COMPOSITION

A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease

A103 COMBINATORIAL EFFECT OF EARLY LIFE ANTIBIOTIC EXPOSURE AND HIGH-FAT DIET ON COLITIS SUSCEPTIBILITY

P244 The first step to IBD prevention exploring rate of pre-clinical inflammation in subset of asymptomatic subjects at risk of IBD: screening stage of the PIONIR trial

A261 INVESTIGATING THE RELATIONSHIP BETWEEN AIR POLLUTION AND BIOMARKERS OF CROHN’S DISEASE IN CANADA

A196 CSF2 AUTOANTIBODIES AS A SEROLOGICAL MARKER FOR CROHN'S DISEASE

Suchergebnisse filtern